# Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations

> **NCT02705846** · — · RECRUITING · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 4260 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** Observation of treatment outcomes via Questionnaire

## Key facts

- **NCT ID:** NCT02705846
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2014-09
- **Primary completion:** 2030-12
- **Final completion:** 2035-12
- **Target enrollment:** 4260 (ESTIMATED)
- **Last updated:** 2025-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02705846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02705846, "Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02705846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*